Spinal muscular atrophy

Spinal muscular atrophy patients in Hong Kong have urged the government to expand subsidised medicine options for adults, including injection therapy, to improve their quality of life. Lui Man-lam, president of the Hong Kong Neuro-Muscular Disease Association, said at a Sunday press conference that oral medicine subsidies for those aged 25 or above began early this year, but adults still lack public funding for injections.